Neuropathology Core
神经病理学核心
基本信息
- 批准号:10176345
- 负责人:
- 金额:$ 40.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAutopsyAwardBiological AssayBiological MarkersBrainBrain regionClinical DataCognitiveConsensusCountryDataDementiaDevelopmentDiagnosticDisciplineDiseaseEnvironmentEvaluationFacultyFormalinFosteringFreezingFutureGuidelinesImageImpaired cognitionIndividualInterdisciplinary StudyInternationalLeadershipMedical StudentsMethodsMissionMolecularNerve DegenerationNeurodegenerative DisordersOutreach ResearchParaffin EmbeddingPathologicPathologic ProcessesPatientsPhysiciansPositioning AttributeProcessReportingResearchResearch PersonnelResource SharingScientistSpecimenStructureTechniquesTechnologyTimeTissue EmbeddingTissuesTrainingTranslational ResearchVisionaging brainbiobankbrain researchbrain tissuedata managementdata qualityeducation researchgraduate studentimaging approachinnovationinnovative technologiesinsightmolecular pathologyneuropathologyrepositoryresearch studystatistics
项目摘要
1. SUMMARY (Neuropathology Core)
The Neuropathology Core supports the vision of the Stanford Alzheimer’s Disease Center (ADRC) to serve as
a shared resource to facilitate and enhance multidisciplinary and interdisciplinary research in Alzheimer’s
disease (AD) and related disorders. The Core is structured to continue its track record of enabling and applying
innovative cutting-edge technologies with emphasis on brain aging and the diversity of pathologic processes
that underlie cognitive impairment and dementia caused by AD and related diseases. The critical functions of
the Neuropathology Core include diagnostic expertise, serving as a biorepository, facilitating innovation, and
training. Over the past five years, the Neuropathology Core has completed over 50 research brain autopsies
and held a leadership position in setting and evaluating national research guidelines for neuropathologic
evaluation of AD. We have banked over 800 tissue specimens, contributed data and biospecimens to local,
regional, national, and international research studies and consortia, and fostered development and
implementation of innovative technologies in translational research. Through the Core, we trained clinicians
and scientists from different disciplines in neuropathology and the molecular pathology of dementia-related
neurodegenerative diseases. The Neuropathology Core will pursue its mission through four Specific Aims. The
Core will provide comprehensive neuropathologic evaluations for physicians and researchers with timely and
comprehensive autopsy reports that describe the neuropathologic features of AD and related diseases
according to the most current guidelines and consensus diagnostic criteria. It will maintain and continue to
grow its highly accessible, but appropriately safeguarded, repository of brain tissue and biospecimens from
carefully and longitudinally characterized patients with cognitive impairment or dementia, as well as cognitively
normal individuals, using methods that increase and maximize tissue and data quality. In doing so, the Core
will empower innovative high-content imaging approaches for both formalin-fixed, paraffin-embedded tissue
and for frozen brain regions to maximize the research value of the Stanford ADRC repository and other brain
banks around the country. Finally, we will maintain a rich training environment for medical and graduate
students, residents, fellows, and junior faculty across departments to teach concepts and state-of-the-art
techniques that advance current interdisciplinary research and foster future advances and insights in brain
aging and neurodegeneration. The Core is organized to maximize integration with all other Cores in the
Stanford ADRC. It also will continue to serve as a hub of support for affiliated ADRCs and independent
research awards through diagnostic practices, molecular assays, and tissue sharing. In doing so, the Core and
Center will continue to contribute nationally to advance our understanding of the pathologic features and
pathophysiologic processes of brain aging, all stages of AD, and related dementias.
1.摘要(神经病理学核心)
神经病理学核心支持斯坦福阿尔茨海默病中心(ADRC)作为
促进和加强阿尔茨海默氏症多学科和跨学科研究的共享资源
疾病(AD)及相关疾病。核心的结构是为了继续其支持和应用的跟踪记录
创新的尖端技术,强调大脑老化和病理过程的多样性
这是阿尔茨海默病和相关疾病导致认知障碍和痴呆症的基础。的关键功能
神经病理学核心包括诊断专业知识,作为生物信息库,促进创新,以及
训练。在过去的五年里,神经病理核心已经完成了50多例脑部尸检研究
并在制定和评估国家神经病理学研究指南方面处于领导地位
对AD的评价。我们已经储存了800多个组织样本,为当地提供了数据和生物标本,
区域、国家和国际研究研究和联合体,并促进发展和
在翻译研究中实施创新技术。通过CORE,我们培训了临床医生
以及来自不同学科的科学家在神经病理学和分子病理学方面与痴呆症相关
神经退行性疾病。神经病理学核心中心将通过四个具体目标来实现其使命。这个
CORE将为医生和研究人员提供全面的神经病理评估,
描述阿尔茨海默病及相关疾病的神经病理特征的综合尸检报告
根据最新的指南和协商一致的诊断标准。它将保持并继续
培养其高度可访问、但受到适当保护的脑组织和生物标本储存库
仔细地和纵向地描述认知障碍或痴呆症患者的特征,以及认知
正常个体,使用提高和最大化组织和数据质量的方法。在此过程中,核心
将为福尔马林固定的石蜡包埋组织提供创新的高含量成像方法
对于冰冻的大脑区域,最大限度地发挥斯坦福ADRC储存库和其他大脑的研究价值
全国各地的银行。最后,我们将为医学和研究生提供丰富的培训环境
跨部门的学生、住院医生、研究员和初级教职员工,教授概念和最新技术
推动当前跨学科研究并促进未来大脑进步和洞察力的技术
衰老和神经退化。核心的组织旨在最大限度地与中的所有其他核心集成
斯坦福大学ADRC。它还将继续作为附属ADRC和独立ADRC的支持中心
通过诊断实践、分子分析和组织共享获得研究奖项。在此过程中,核心和
中心将继续在全国范围内促进我们对病理特征和
脑老化、阿尔茨海默病各阶段及相关痴呆的病理生理过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas J Montine其他文献
Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein
- DOI:
10.1186/1742-2094-4-2 - 发表时间:
2007-01-04 - 期刊:
- 影响因子:10.100
- 作者:
Jinghua Jin;Feng-Shiun Shie;Jun Liu;Yan Wang;Jeanne Davis;Aimee M Schantz;Kathleen S Montine;Thomas J Montine;Jing Zhang - 通讯作者:
Jing Zhang
Thomas J Montine的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas J Montine', 18)}}的其他基金
Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry
项目 2:使用元素报告仪和质谱法对 CSF 蛋白进行粒子和脑图谱分析
- 批准号:
10359193 - 财政年份:2020
- 资助金额:
$ 40.89万 - 项目类别:
Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry
项目 2:使用元素报告仪和质谱法对 CSF 蛋白进行粒子和脑图谱分析
- 批准号:
10573262 - 财政年份:2020
- 资助金额:
$ 40.89万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 40.89万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 40.89万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 40.89万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 40.89万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 40.89万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 40.89万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 40.89万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 40.89万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 40.89万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 40.89万 - 项目类别:














{{item.name}}会员




